Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-10-31

Clinical Trial Update: Prader-Willi Syndrome and Appetite [Phase 3]

View source ↗

Summary

Phase 3 trial for Prader-Willi syndrome focusing on hyperphagia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of British Columbia | Conditions: Hyperphagia, Prader-Willi Syndrome | Phase 3 | Status: TERMINATED